Buy Semaglutide 10 mg in Australia
Semaglutide 10 mg costs $119.99 a vial at Australian Research Peptides, an Australian supplier to laboratories and researchers. It is in stock, and orders paid before 12pm Sydney time on a business day are posted the same day. Its 10 mg certificate shows 99.262% purity. Studied in metabolic research, Semaglutide is a laboratory-made copy of GLP-1, a hormone released by the gut, with two of its 31 amino acids swapped and a fatty chain attached so it lasts longer. In vitro research purposes only.
Metabolic Research · Lyophilised Powder · HPLC-tested · SKU 78441
$119.99
1
Presentation
10 mg per vial
Grade
High-Purity Research Grade
Form
Lyophilised Powder
Category
Metabolic Research
Same-day dispatch on business-day orders completed before 12pm Sydney time, Mon–Fri
Tracked shipping Australia-wide ·typically 1–2 business days to most areas by Express Post · free post over $199, free Express over $299
Batch certificates — published in the COA library
For in vitro research purposes only. Not for human consumption. Not for animal consumption. This product is not a drug, food, cosmetic, or dietary supplement. ARP gives no usage, medical or therapeutic guidance of its own.
Semaglutide · 10 mg
$119.99
About Semaglutide
Semaglutide is studied in metabolic research, in cell culture and in animal models. It is described as acting at a single receptor, the GLP-1 receptor; a receptor is the docking point on a cell that a hormone fits into. That one target is the quickest way to tell it apart from Retatrutide, which ARP lists as a three-receptor peptide.
Semaglutide is a modified copy of GLP-1 (glucagon-like peptide-1), a hormone released by cells in the gut. Two of its amino acids are swapped compared with the natural hormone, and a fatty chain is attached to it. Published work says that chain is there to grip albumin, the most common protein in blood, and to hold off the enzymes that break peptides down.
Lau 2015, the paper that first described semaglutide, measured how tightly it binds the GLP-1 receptor in a laboratory test: 0.38 nM, about three times weaker than liraglutide, an earlier GLP-1 copy. The fatty chain is the feature that sets it apart from the natural hormone. ARP supplies semaglutide as a reference material for in vitro research, meaning work in glassware and cell culture.
Australian Research Peptides lists semaglutide in Australia as a single 10 mg vial of freeze-dried powder, supplied strictly as a reference material for in vitro research and not as a medicine. People search for it as semaglutide, sema and semaglutide peptide. Vials are held and posted within Australia rather than imported on order. The peptide is tested by HPLC, which separates a sample and reports its purity, and by mass spectrometry, which weighs the molecule to confirm its identity, with the measured figures published on its certificate in the COA library.
BAC water (bacteriostatic water) is also in our range.
The peptide calculator works out the mg/mL concentration of a reconstituted vial.
Content reviewed
Further reading: Where Is the Best Place to Buy Peptides in Australia?
Semaglutide specifications, storage and shipping
- Compound: Semaglutide
- Also known as: Semaglutide
- Class: Acylated GLP-1 receptor agonist peptide
- Appearance: White to off-white lyophilised (freeze-dried) powder
- Sizes & SKUs: 10 mg (78441)
- Presentation: sealed glass vial
- Form: Lyophilised Powder
- Grade: High-purity research grade
- Purity verification: HPLC-assayed to a minimum of 99% purity — the measured result is stated on the published Certificate of Analysis
- Identity confirmation: Mass spectrometry
- Certificates: issued by Janoshik, an independent laboratory, and published in the COA library
- Classification: In vitro research purposes only — laboratory reference material
- Lyophilised — long term
- −20 °C to −80 °C — long-term storage
- Lyophilised — short term
- 2–8 °C — refrigerated, for a few months
- Reconstituted
- 2–8 °C — use within 8–12 weeks
Semaglutide is HPLC-tested for purity and confirmed by mass spectrometry for identity. The full laboratory report is published in the COA library. Semaglutide is tested by Janoshik, an independent laboratory, commissioned by the manufacturer rather than by Australian Research Peptides.
- Semaglutide 10 mg: assayed purity 99.262% · measured content 11.32 mg · analysed 27 May 2026
Business-day orders before 12pm Sydney time are dispatched the same day with tracked shipping. Standard delivery within Australia typically takes 2–5 business days. See Shipping & Delivery for details, and follow your parcel on the Track Order page.
For in vitro research purposes only. Not for human consumption. Not for animal consumption. Not a drug, food, cosmetic, or dietary supplement. No therapeutic or medical claims are made.
Questions about Semaglutide
This question guide from Australian Research Peptides covers Semaglutide in Australia: what the listing contains, live buying and delivery questions, research context, handling, testing and comparisons. Start with the quick answers, then open the topic group that matches your search.
Buying, price and availability
Semaglutide is sold in Australia by Australian Research Peptides (ARP), which lists it as one 10 mg vial of freeze-dried powder in its Metabolic Research range and posts it from within Australia, so nothing crosses a border. Buyers also find it by typing sema or semag. It is tested by HPLC before release, and the CoA library lists the certificates published for each product. Business-day orders paid before the same-day cut-off go out that afternoon by Express Post or tracked post to every state and territory. Orders are paid by PayID or bank transfer.
Semaglutide is supplied in Australia by Australian Research Peptides Pty Ltd, an Australian company that operates from Sydney and posts stock it already holds rather than shipping vials in from abroad. Semaglutide is tested by HPLC, which separates a sample and reports its purity, before release, and ARP's CoA library shows which strengths have a published certificate. Orders settle by PayID or bank transfer — no wallets, no instalment accounts, no crypto.
Semaglutide is sold by Australian Research Peptides at one fixed Australian-dollar price per 10 mg vial, with no per-milligram rate quoted beside it because only one strength exists. That price is final, not provisional. Postage is separate and depends on the delivery option chosen for the order.
Semaglutide is listed and dispatched in Australia by Australian Research Peptides, which sells it as one 10 mg vial of freeze-dried powder and takes orders online only. It is paid for by PayID or direct bank transfer; digital wallets, buy-now-pay-later and crypto are not accepted. Stock is held in Australia rather than imported to order, so the parcel travels domestically and leaves once a vial is on hand and the payment has been matched to the order.
Identity, names and exact format
Semaglutide is a laboratory-made peptide, a short chain of 31 amino acids, modelled on GLP-1, a hormone the gut releases, with two amino acids swapped and a fatty chain attached to make it last longer. Chemistry databases list it as ChEBI:167574 and DrugBank DB13928. Australian Research Peptides sells it as freeze-dried powder for laboratory research.
Semiglutide is a common misspelling of semaglutide, and both spellings mean the same GLP-1-based research peptide; the extra 'i' comes from how the word sounds, not from a second compound. The plural, semiglutides, is typed just as often. Australian Research Peptides catalogues the correct spelling and supplies that freeze-dried vial to laboratories and researchers in Australia, so the material, the batch certificate and the listing are identical whichever way it is typed.
An acylated analogue is a peptide built as a copy of another peptide with a fatty chain added to it: 'analogue' means the copy, and 'acylated' is the chemists' word for attaching that chain. For semaglutide the copied peptide is GLP-1, a gut hormone, and the chain is a fatty diacid (a fatty acid with an acid group at each end) fixed to the lysine at position 26. The published reason for adding it is to grip albumin, the most common protein in blood, and resist the enzymes that break peptides down. That describes how the molecule was built to last, not an effect.
Semaglutide has 31 amino acids, the building blocks of a peptide chain, and differs from the human GLP-1 hormone it copies at only two of them. Position 8 carries Aib, an amino acid not found in human proteins, and position 34 carries arginine. The fatty chain attached at position 26 is not an amino acid, so it does not add to the count. Australian Research Peptides does not publish a full letter-by-letter sequence for semaglutide.
Semaglutide is catalogued under its own generic name almost everywhere, with no separate compound name and no development code in the records Australian Research Peptides checked. Chemistry databases index the identical molecule as ChEBI:167574 and DrugBank DB13928. Buyers type sema and semag, and ARP's site search finds semaglutide under both. GLP-1 is the hormone semaglutide copies, not a synonym for it. ARP warehouses the peptide locally and HPLC-tests it; its CoA library is the page naming the strengths a published certificate covers.
Research context and evidence
In laboratory tests, Semaglutide binds one receptor, the GLP-1 receptor, and switches it on; a receptor is the docking point on a cell that a hormone fits into, and GLP-1 is the gut hormone semaglutide copies. GLP-1 belongs to the incretins, gut hormones released after food. Lau 2015, the paper in the Journal of Medicinal Chemistry that first described semaglutide, measured its grip on that receptor at 0.38 nM, three times weaker than liraglutide, an earlier GLP-1 copy. That figure comes from a laboratory binding test, not a result in anybody.
Semaglutide is studied in metabolic research, and Gabery's 2020 study in JCI Insight is a frequently cited example: work in rodents mapping where the GLP-1 receptor sits in the brain and which areas the molecule reaches. Australian Research Peptides supplies the vial as freeze-dried powder for laboratory work and draws no conclusion of its own from that research.
Handling, storage and measurements
That is normal: Semaglutide arrives as ten milligrams of freeze-dried powder, which spreads over the base of a glass vial as little more than a pale smear. Freeze-drying pulls the water out under vacuum and leaves a fragile, airy cake that often collapses into a ring or shifts to one side in the post. A vial that looks almost empty is the standard look at this amount; an unbroken seal is the check that counts.
Semaglutide should be stored as freeze-dried powder at -20 °C, sealed and away from light and moisture, as published peptide handling guidance advises; its fatty chain was built to survive blood, not a warm shelf. Before opening, let the cold vial warm to room temperature inside a closed, dry container, so moisture does not condense on the powder. Any solution made from it is best frozen and thawed as few times as possible.
Semaglutide is reconstituted, meaning dissolved back into a liquid, by adding a suitable diluent to the freeze-dried powder in its vial before any laboratory work. Send the liquid down the inside of the glass rather than straight onto the powder, then rock the vial slowly, without shaking, until nothing solid is left. The amount of liquid chosen sets how strong the finished solution is.
Reconstituted Semaglutide, meaning the powder once dissolved, has no published stability study behind it, so Australian Research Peptides' own handling figure applies: a fridge at 2–8 °C, with twelve weeks the outer limit and eight the comfortable one. The amino acid swapped in at position 8 was designed to resist an enzyme in blood, which is a different problem from a vial on a cold shelf. Thawed material should not be refrozen.
Bubbles are the usual explanation, because Semaglutide dissolves readily and milkiness appearing straight after mixing is normally air trapped by shaking the vial too hard; left standing, the liquid clears from the top downwards. Haze that persists is a different matter and suggests solid which never dissolved, or peptide that has clumped together. A finished preparation should be clear and colourless with nothing suspended in it.
Semaglutide is dissolved in an aqueous diluent for laboratory work, because it arrives as a dry white to off-white freeze-dried powder. No liquid comes with the vial; the diluent is chosen by the laboratory for its method, and the volume added sets the concentration of the finished solution.
Testing and batch documents
Semaglutide is tested two ways before it is supplied in Australia: HPLC, which separates the sample and reports purity, and mass spectrometry, which weighs the molecule to confirm its identity. HPLC purity is the share of the sample sitting in the main peak. Identity is the harder half for semaglutide, because the attached fatty chain has to show up in the measured weight. A matching certificate is currently published for this product and strength. Open the 10 mg certificate.
Ordering, payment and Australian delivery
Two Semaglutide vials qualify for free standard tracked post in Australia, but only just: they clear the threshold by the narrowest margin of any product Australian Research Peptides stocks, so the order total is worth checking. One vial does not qualify. Free Express Post starts at a higher figure that two vials do not reach. The check uses the goods total before any discount code, so a code cannot push the order back under.
Semaglutide delivery takes 1–2 business days by Express Post for much of Australia and 2–5 business days by standard tracked post, counted from when payment is matched, not from when the order is placed. A bank transfer still in transit overnight has not started that clock, while PayID usually clears in minutes and closes the gap. Dispatch is the parcel leaving; delivery is the carrier arriving.
PayID and bank transfer are the two methods on a Semaglutide order, both sent from the buyer's own banking app, so no bank login or card details are ever entered on Australian Research Peptides' website. PayID and a bank transfer are matched by hand against the reference printed on the order.
A Semaglutide vial comes with nothing else: it holds dry powder only, with no diluent, no measuring equipment and no second compound inside the sealed glass. What a laboratory dissolves it in, and how it measures the solution, depends on its own method and the work in hand.
Access and regulatory questions
Australian Research Peptides sells semaglutide in Australia as a laboratory research material, not as a medicine, supplied for in vitro research only, meaning work in glassware and cell culture, and not for human or veterinary use. Because it ships from within Australia, the buyer imports nothing and no customs declaration is involved. Anyone ordering it is responsible for working within the rules that govern their own laboratory.
Semaglutide is approved in the United States as an ingredient of registered prescription medicines, though not in the form a research supplier ships, which is unregistered freeze-dried powder. The Food and Drug Administration first approved a finished prescription product containing semaglutide in 2017, and further products in 2019 and 2021, each with a label, a set strength and a manufacturer standing behind it. Laboratory powder has none of those things.
Semaglutide is not banned in sport: the World Anti-Doping Agency (WADA) prohibited list does not name it in any category, though it does sit on WADA's Monitoring Program, which collects usage data without penalising anyone. Because it is an approved medicine in many countries, it also falls outside the catch-all ban on unapproved experimental substances. Sport Integrity Australia holds the current position for Australian competitors.
Semaglutide shipped in from a foreign vendor can be stopped at the border, and a package stopped there is usually lost for good — the money and the material both go. Australian Research Peptides' semaglutide does not face that risk, because ARP posts it from within Australia rather than importing to order, so it travels domestically to the buyer. The Australian Border Force sets out the kinds of goods it acts against.
No, semaglutide from Australian Research Peptides is not a registered medicine and is not sold as one; it is supplied only as a reference material for in vitro laboratory research. ARP does not offer it as a substitute for a registered product, and names no such product for comparison. The vial holds freeze-dried powder for laboratory work.
Chemist Warehouse does dispense the registered semaglutide medicines on prescription, so for that question the answer is yes — but what Australian Research Peptides lists is a different product. ARP supplies semaglutide as a research compound, freeze-dried in a vial for in vitro laboratory work. The molecule is shared; the product, the supply route and the permitted purpose are not.